Surveyor Capital
45 portfolio companies · 7 on the map · $4B raised · 4 cities
Portfolio map
7 Surveyor Capital portfolio companies on the map.
Portfolio companies

Ocular Therapeutix
Bedford
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Pharmaceutical Manufacturing$1.2BEst. 2006
Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Zentalis
San Diego
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Biotechnology Research$896.6M
Compass Pathways
London
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Mental Health Care$771.2MEst. 2016
Artiva Biotherapeutics
San Diego
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Biotechnology Research$198MEst. 2019- A
Allakos
Redwood City
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Biotechnology ResearchPublic Plexium
San Diego
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Biotechnology ResearchSeries CEst. 2018
More portfolio companies
35 more Surveyor Capital investments we track beyond the map — 45 tracked in total.
Oruka TherapeuticsWaltham · Post-IPO Equity
Triana BiomedicinesLexington · Series B
enGeneVancouver · Post-IPO Equity
VeraDermicsNew Haven · Series C
Forge BiologicsGrove City · Series B
Soley TherapeuticsSan Francisco · Series C
Avenzo TherapeuticsSan Diego · Series B
Rapport TherapeuticsBoston · Series B
Design TherapeuticsSolana Beach · Series B
Arbor BiotechnologiesCambridge · Series C
BBOTPalo Alto · Post-IPO Equity
AmbAgon TherapeuticsSan Francisco · Series A
Boundless BioLa Jolla · Series C
Enliven TherapeuticsBoulder · Series B
ProfoundBioSeattle · Series B
Neuron23San Francisco · Series C
Marea TherapeuticsSan Francisco · Series B
AffinivaxCambridge · Series C
AttralusSan Francisco · Series B
Vanqua BioChicago · Series B
Mariana OncologyWatertown · Series B
ArvinasNew Haven · Post-IPO Equity
Allogene TherapeuticsSouth San Francisco · Convertible Note
VistaGenSan Francisco · Post-IPO Equity
Lyra TherapeuticsWatertown · Post-IPO Equity
DTx PharmaSan Diego · Series B
ImmPACT BioCamarillo · Series B
Cullinan TherapeuticsCambridge · Post-IPO Equity
Ikena OncologyBoston · Series B
Point BiopharmaIndianapolis · Post-IPO Equity
AkouosBoston · Series B
VYNE TherapeuticsMenlo Park · Post-IPO Equity
Chinook TherapeuticsVancouver · Post-IPO Equity
Viracta TherapeuticsCardiff By The Sea · Post-IPO Equity
Pieris PharmaceuticalsBoston · Post-IPO Equity
Portfolio map
7 Surveyor Capital portfolio companies on the map.